Latest news with #Planets


India Today
3 days ago
- Science
- India Today
Researchers spot the perfect place to land humans on Mars
As the rush to send missions and eventually humans to Mars becomes intense with Elon Musk planning the first uncrewed mission by 2026, researchers are fast at work to identify the perfect location to land at the University of Mississippi have now found one such spot, which could be conducive for the first humans to land on the Red spot is located in the Amazonis Planitia region, which is around the middle latitudes of the planet and is being considered for the maiden human expedition as it gets enough sunlight for power, and is still cold enough to preserve ice near the surface. "If we're going to send humans to Mars, you need H2O and not just for drinking, but for propellant and all manner of applications. And finding it close to the surface is helpful because we can easily extract it and use it. This is called in situ resource utilisation, and it's an important practice for any space exploration," Erica Luzzi, a planetary geologist and postdoctoral researcher, a study published in the Journal of Geophysical Research: Planets, the team tracks a potential water source for future human high-resolution orbital imagery, the team analysed the Martian surface and found evidence of ice less than 1 meter below the planet's surface in the Amazonis Planitia region. The team identified ice-exposing craters, polygonal terrain and other morphologies that typically suggest ice near the surface."For the moon, it would take us one week, more or less, to go back and forth to Earth for resupply. But for Mars, it would take months. So, we have to be prepared for not having resupply from Earth for extended periods. The most important resources are oxygen to breathe and water to drink. That's what makes our candidate landing site really promising," Giacomo Nodjoumi, co-author of the paper get samples of the ice, humans would have to send a robot or an exploration mission."The next step would be radar analyses to better understand the depth and patchiness of the ice," the Ole Miss researcher said. "The lag deposit, material on top of the ice, might vary, which affects whether the ice is preserved."- EndsTrending Reel


South Wales Guardian
18-06-2025
- Health
- South Wales Guardian
Petition for cancer treatment to be funded reaches 46,000 signatories
The cancer charity Planets is leading the campaign for the treatment, known as selective internal radiation therapy (Sirt), to be made available through the NHS after it was approved for use more than a year ago. A spokesman for the charity said: 'Every year approximately 6,000 people in the UK are diagnosed with NETs, a complex and often slow-growing cancer that can be difficult to detect and treat. 'Many patients develop tumours in the liver where the treatment could offer significant benefits. 'Sirt involves injecting millions of tiny radioactive beads called microspheres – smaller than the width of a human hair – into the blood supply in the liver to destroy cancer cells.' The spokesman said that despite approval by the National Institute for Health and Care Excellence (NICE) in May 2024, NHS England had yet to commission it meaning that patients had no timetable for when it might become available. He added that Sirt was already available on the NHS for patients whose liver cancer developed in the organ directly or which had spread to it from the bowel but NET patients remained excluded. Layla Stephen, a NET patient from Hampshire and director of strategy and finance for Planets, said: 'Patients are missing out simply because of red tape. 'Without NHS commissioning, only those that can afford to go private have access to Sirt and that is simply not right or fair – we need to change this.' Ms Stephen added: 'In a statement earlier this year, NHS England said it was developing a national policy on Sirt to ensure all patients across England have the best possible treatment, yet there is still no confirmed timeline despite approval in May last year, leaving patients in limbo and suffering agonising uncertainty.' Caroline Nokes, Conservative MP for Romsey and Southampton North, has written to health and social care secretary Wes Streeting about the issue. She said: 'Constituents of mine with neuroendocrine tumours should not be caught in a bureaucratic limbo when effective treatment is both available and approved. There needs to be fairness and transparency for these patients.' An NHS spokeswoman said previously: 'The NHS understands the concerns raised about access to selective internal radiation therapy (Sirt) for neuroendocrine tumours in the liver. 'The health service is currently reviewing a clinical proposal and developing a new national mandated NHS policy on Sirt to ensure all patients across England have the best possible treatment for their liver metastases.' The petition can be found at:


The Independent
18-06-2025
- Health
- The Independent
Petition for cancer treatment to be funded reaches 46,000 signatories
More than 46,000 people have signed a petition calling on the NHS to fund a life-changing cancer treatment for patients with neuroendocrine tumours (NETs). The cancer charity Planets is leading the campaign for the treatment, known as selective internal radiation therapy (Sirt), to be made available through the NHS after it was approved for use more than a year ago. A spokesman for the charity said: 'Every year approximately 6,000 people in the UK are diagnosed with NETs, a complex and often slow-growing cancer that can be difficult to detect and treat. 'Many patients develop tumours in the liver where the treatment could offer significant benefits. 'Sirt involves injecting millions of tiny radioactive beads called microspheres – smaller than the width of a human hair – into the blood supply in the liver to destroy cancer cells.' The spokesman said that despite approval by the National Institute for Health and Care Excellence (NICE) in May 2024, NHS England had yet to commission it meaning that patients had no timetable for when it might become available. He added that Sirt was already available on the NHS for patients whose liver cancer developed in the organ directly or which had spread to it from the bowel but NET patients remained excluded. Layla Stephen, a NET patient from Hampshire and director of strategy and finance for Planets, said: ' Patients are missing out simply because of red tape. 'Without NHS commissioning, only those that can afford to go private have access to Sirt and that is simply not right or fair – we need to change this.' Ms Stephen added: 'In a statement earlier this year, NHS England said it was developing a national policy on Sirt to ensure all patients across England have the best possible treatment, yet there is still no confirmed timeline despite approval in May last year, leaving patients in limbo and suffering agonising uncertainty.' Caroline Nokes, Conservative MP for Romsey and Southampton North, has written to health and social care secretary Wes Streeting about the issue. She said: 'Constituents of mine with neuroendocrine tumours should not be caught in a bureaucratic limbo when effective treatment is both available and approved. There needs to be fairness and transparency for these patients.' An NHS spokeswoman said previously: 'The NHS understands the concerns raised about access to selective internal radiation therapy (Sirt) for neuroendocrine tumours in the liver. 'The health service is currently reviewing a clinical proposal and developing a new national mandated NHS policy on Sirt to ensure all patients across England have the best possible treatment for their liver metastases.' The petition can be found at:


North Wales Chronicle
18-06-2025
- Health
- North Wales Chronicle
Petition for cancer treatment to be funded reaches 46,000 signatories
The cancer charity Planets is leading the campaign for the treatment, known as selective internal radiation therapy (Sirt), to be made available through the NHS after it was approved for use more than a year ago. A spokesman for the charity said: 'Every year approximately 6,000 people in the UK are diagnosed with NETs, a complex and often slow-growing cancer that can be difficult to detect and treat. 'Many patients develop tumours in the liver where the treatment could offer significant benefits. 'Sirt involves injecting millions of tiny radioactive beads called microspheres – smaller than the width of a human hair – into the blood supply in the liver to destroy cancer cells.' The spokesman said that despite approval by the National Institute for Health and Care Excellence (NICE) in May 2024, NHS England had yet to commission it meaning that patients had no timetable for when it might become available. He added that Sirt was already available on the NHS for patients whose liver cancer developed in the organ directly or which had spread to it from the bowel but NET patients remained excluded. Layla Stephen, a NET patient from Hampshire and director of strategy and finance for Planets, said: 'Patients are missing out simply because of red tape. 'Without NHS commissioning, only those that can afford to go private have access to Sirt and that is simply not right or fair – we need to change this.' Ms Stephen added: 'In a statement earlier this year, NHS England said it was developing a national policy on Sirt to ensure all patients across England have the best possible treatment, yet there is still no confirmed timeline despite approval in May last year, leaving patients in limbo and suffering agonising uncertainty.' Caroline Nokes, Conservative MP for Romsey and Southampton North, has written to health and social care secretary Wes Streeting about the issue. She said: 'Constituents of mine with neuroendocrine tumours should not be caught in a bureaucratic limbo when effective treatment is both available and approved. There needs to be fairness and transparency for these patients.' An NHS spokeswoman said previously: 'The NHS understands the concerns raised about access to selective internal radiation therapy (Sirt) for neuroendocrine tumours in the liver. 'The health service is currently reviewing a clinical proposal and developing a new national mandated NHS policy on Sirt to ensure all patients across England have the best possible treatment for their liver metastases.' The petition can be found at:


Glasgow Times
18-06-2025
- Health
- Glasgow Times
Petition for cancer treatment to be funded reaches 46,000 signatories
The cancer charity Planets is leading the campaign for the treatment, known as selective internal radiation therapy (Sirt), to be made available through the NHS after it was approved for use more than a year ago. A spokesman for the charity said: 'Every year approximately 6,000 people in the UK are diagnosed with NETs, a complex and often slow-growing cancer that can be difficult to detect and treat. Layla Stephen, a neuroendocrine tumour (NET) patient from Hampshire and director of strategy and finance for Planets (Planets Cancer Charity/PA) 'Many patients develop tumours in the liver where the treatment could offer significant benefits. 'Sirt involves injecting millions of tiny radioactive beads called microspheres – smaller than the width of a human hair – into the blood supply in the liver to destroy cancer cells.' The spokesman said that despite approval by the National Institute for Health and Care Excellence (NICE) in May 2024, NHS England had yet to commission it meaning that patients had no timetable for when it might become available. He added that Sirt was already available on the NHS for patients whose liver cancer developed in the organ directly or which had spread to it from the bowel but NET patients remained excluded. Layla Stephen, a NET patient from Hampshire and director of strategy and finance for Planets, said: 'Patients are missing out simply because of red tape. 'Without NHS commissioning, only those that can afford to go private have access to Sirt and that is simply not right or fair – we need to change this.' Microspheres, tiny radioactive beads smaller than the width of a human hair, are injected into the blood supply in the liver to destroy cancer cells through Sirt (Planets/PA) Ms Stephen added: 'In a statement earlier this year, NHS England said it was developing a national policy on Sirt to ensure all patients across England have the best possible treatment, yet there is still no confirmed timeline despite approval in May last year, leaving patients in limbo and suffering agonising uncertainty.' Caroline Nokes, Conservative MP for Romsey and Southampton North, has written to health and social care secretary Wes Streeting about the issue. She said: 'Constituents of mine with neuroendocrine tumours should not be caught in a bureaucratic limbo when effective treatment is both available and approved. There needs to be fairness and transparency for these patients.' An NHS spokeswoman said previously: 'The NHS understands the concerns raised about access to selective internal radiation therapy (Sirt) for neuroendocrine tumours in the liver. 'The health service is currently reviewing a clinical proposal and developing a new national mandated NHS policy on Sirt to ensure all patients across England have the best possible treatment for their liver metastases.' The petition can be found at: